[(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate

C68H110O33 — CID 22832591

IUPAC[(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate
SMILESCOC1C(O)[C@H](OC2C(O)[C@H](O[C@@H]3CO[C@@H](OC4C(O)[C@H](O[C@@H]5OC(CO)[C@@H](O)C(O[C@@H]6OC(CO)[C@@H](O)C(OC)C6O)C5O)CO[C@H]4O[C@H]4CC[C@]5(C)[C@@H]6CCC78C(=O)O[C@@](C)(C[C@H](CC(C)C)OC(C)=O)[C@H]7CC[C@@]8(C)C6=CC[C@H]5C4(C)C)C(O)C3O)OC(CO)[C@H]2O)OC(CO)[C@H]1O
InChIInChI=1S/C68H110O33/c1-27(2)19-29(90-28(3)73)20-67(8)39-14-17-66(7)31-11-12-38-64(4,5)40(15-16-65(38,6)30(31)13-18-68(39,66)63(85)101-67)97-62-56(46(79)37(26-89-62)96-59-51(84)55(45(78)35(24-72)92-59)99-61-49(82)53(87-10)43(76)33(22-70)94-61)100-57-47(80)41(74)36(25-88-57)95-58-50(83)54(44(77)34(23-71)91-58)98-60-48(81)52(86-9)42(75)32(21-69)93-60/h11,27,29-30,32-62,69-72,74-84H,12-26H2,1-10H3/t29-,30+,32?,33?,34?,35?,36+,37+,38-,39+,40-,41?,42+,43+,44+,45+,46?,47?,48?,49?,50?,51?,52?,53?,54?,55?,56?,57-,58-,59-,60-,61-,62-,65+,66-,67-,68?/m0/s1
InChIKeyUTTMVFMTWNLRGZ-NPZPPDJRSA-N
MW1455.59 g/mol
LogP-3.85
Rot. Bonds23

About [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate

[(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate (PubChem CID 22832591) has the molecular formula C68H110O33 and a molecular weight of 1455.59 g/mol. Its IUPAC name is [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate.

Molecular Properties

Compound Name[(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate
PubChem CID22832591
Molecular FormulaC68H110O33
Molecular Weight1455.59 g/mol
Exact Mass1454.69
IUPAC Name[(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate
SMILESCOC1C(O)[C@H](OC2C(O)[C@H](O[C@@H]3CO[C@@H](OC4C(O)[C@H](O[C@@H]5OC(CO)[C@@H](O)C(O[C@@H]6OC(CO)[C@@H](O)C(OC)C6O)C5O)CO[C@H]4O[C@H]4CC[C@]5(C)[C@@H]6CCC78C(=O)O[C@@](C)(C[C@H](CC(C)C)OC(C)=O)[C@H]7CC[C@@]8(C)C6=CC[C@H]5C4(C)C)C(O)C3O)OC(CO)[C@H]2O)OC(CO)[C@H]1O
InChIInChI=1S/C68H110O33/c1-27(2)19-29(90-28(3)73)20-67(8)39-14-17-66(7)31-11-12-38-64(4,5)40(15-16-65(38,6)30(31)13-18-68(39,66)63(85)101-67)97-62-56(46(79)37(26-89-62)96-59-51(84)55(45(78)35(24-72)92-59)99-61-49(82)53(87-10)43(76)33(22-70)94-61)100-57-47(80)41(74)36(25-88-57)95-58-50(83)54(44(77)34(23-71)91-58)98-60-48(81)52(86-9)42(75)32(21-69)93-60/h11,27,29-30,32-62,69-72,74-84H,12-26H2,1-10H3/t29-,30+,32?,33?,34?,35?,36+,37+,38-,39+,40-,41?,42+,43+,44+,45+,46?,47?,48?,49?,50?,51?,52?,53?,54?,55?,56?,57-,58-,59-,60-,61-,62-,65+,66-,67-,68?/m0/s1
InChIKeyUTTMVFMTWNLRGZ-NPZPPDJRSA-N
XLogP-3.85
TPSA485.27 Ų
H-Bond Donors15
H-Bond Acceptors33
Rotatable Bonds23
Heavy Atoms101
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001455.59
LogP ≤ 5-3.85
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate?
The IUPAC name of [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate (CID 22832591) is [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate.
What is the SMILES notation for [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate?
The canonical SMILES for [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate is COC1C(O)[C@H](OC2C(O)[C@H](O[C@@H]3CO[C@@H](OC4C(O)[C@H](O[C@@H]5OC(CO)[C@@H](O)C(O[C@@H]6OC(CO)[C@@H](O)C(OC)C6O)C5O)CO[C@H]4O[C@H]4CC[C@]5(C)[C@@H]6CCC78C(=O)O[C@@](C)(C[C@H](CC(C)C)OC(C)=O)[C@H]7CC[C@@]8(C)C6=CC[C@H]5C4(C)C)C(O)C3O)OC(CO)[C@H]2O)OC(CO)[C@H]1O.
What is the InChIKey of [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate?
The InChIKey is UTTMVFMTWNLRGZ-NPZPPDJRSA-N. The full InChI is InChI=1S/C68H110O33/c1-27(2)19-29(90-28(3)73)20-67(8)39-14-17-66(7)31-11-12-38-64(4,5)40(15-16-65(38,6)30(31)13-18-68(39,66)63(85)101-67)97-62-56(46(79)37(26-89-62)96-59-51(84)55(45(78)35(24-72)92-59)99-61-49(82)53(87-10)43(76)33(22-70)94-61)100-57-47(80)41(74)36(25-88-57)95-58-50(83)54(44(77)34(23-71)91-58)98-60-48(81)52(86-9)42(75)32(21-69)93-60/h11,27,29-30,32-62,69-72,74-84H,12-26H2,1-10H3/t29-,30+,32?,33?,34?,35?,36+,37+,38-,39+,40-,41?,42+,43+,44+,45+,46?,47?,48?,49?,50?,51?,52?,53?,54?,55?,56?,57-,58-,59-,60-,61-,62-,65+,66-,67-,68?/m0/s1.
What are the key properties of [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate?
[(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate has a molecular weight of 1455.59 g/mol, XLogP of -3.85, 23 rotatable bonds, 15 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-[(2S,5S,6S,12S,13R,16S,18R)-16-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,5R)-5-[(2S,5R)-4-[(2S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-6-yl]-4-methylpentan-2-yl] acetate is sourced from PubChem (CID 22832591), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).